In this study, we identified NSD2, a histone methylation transferase, as capable of impairing the intestinal barrier through an ERN1–JNK pathway‐mediated inflammatory response, thereby promoting NASH progression. This evidence concerns the gene PRDM9 and metabolic dysfunction-associated steatohepatitis.